JP2024541909A - 乳がんの腫瘍微小環境タイプ - Google Patents

乳がんの腫瘍微小環境タイプ Download PDF

Info

Publication number
JP2024541909A
JP2024541909A JP2024524493A JP2024524493A JP2024541909A JP 2024541909 A JP2024541909 A JP 2024541909A JP 2024524493 A JP2024524493 A JP 2024524493A JP 2024524493 A JP2024524493 A JP 2024524493A JP 2024541909 A JP2024541909 A JP 2024541909A
Authority
JP
Japan
Prior art keywords
group
hla
tme
signature
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024524493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541909A5 (https=
Inventor
ガリーレヴァ，マリア
クホルコヴァ，スヴェトラーナ
コトロフ，ニキータ
ゾトワ，アナスタシア
バリエフ，アイヴァン
バガエブ，アレクサンダー
シャムスディノヴァ，ダイアナ
エリアス－ノミー，クリストル
バタソヴァ，アンナ
アンティシェバ，ゾイア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BostonGene Corp
Original Assignee
BostonGene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BostonGene Corp filed Critical BostonGene Corp
Publication of JP2024541909A publication Critical patent/JP2024541909A/ja
Publication of JP2024541909A5 publication Critical patent/JP2024541909A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2024524493A 2021-10-29 2022-10-28 乳がんの腫瘍微小環境タイプ Pending JP2024541909A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163273171P 2021-10-29 2021-10-29
US63/273,171 2021-10-29
PCT/US2022/048191 WO2023076574A1 (en) 2021-10-29 2022-10-28 Tumor microenvironment types in breast cancer

Publications (2)

Publication Number Publication Date
JP2024541909A true JP2024541909A (ja) 2024-11-13
JP2024541909A5 JP2024541909A5 (https=) 2025-08-06

Family

ID=84421443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024524493A Pending JP2024541909A (ja) 2021-10-29 2022-10-28 乳がんの腫瘍微小環境タイプ

Country Status (5)

Country Link
EP (2) EP4423301B1 (https=)
JP (1) JP2024541909A (https=)
AU (1) AU2022376433A1 (https=)
CA (1) CA3236872A1 (https=)
WO (1) WO2023076574A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202540200A (zh) 2023-12-01 2025-10-16 美商基利科學股份有限公司 抗ｆａｐ－ｌｉｇｈｔ融合蛋白及其用途
WO2025259871A1 (en) 2024-06-14 2025-12-18 Gilead Sciences, Inc. Anti-ccr8 antibodies and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202209539D0 (en) 2017-06-13 2022-08-10 Bostongene Corp Systems and methods for identifying cancer treatments from normalized biomarker scores
US11988672B2 (en) * 2019-11-26 2024-05-21 University Of South Carolina CCL24 as a diagnostic and therapeutic target for breast cancer
JP7541585B2 (ja) 2020-03-12 2024-08-28 ボストンジーン コーポレイション 発現データのデコンボリューションのためのシステム及び方法

Also Published As

Publication number Publication date
WO2023076574A1 (en) 2023-05-04
EP4423301B1 (en) 2025-12-10
EP4692374A2 (en) 2026-02-11
EP4692374A3 (en) 2026-04-22
AU2022376433A1 (en) 2024-05-09
CA3236872A1 (en) 2023-05-04
EP4423301A1 (en) 2024-09-04

Similar Documents

Publication Publication Date Title
US20240006029A1 (en) Systems and methods for predicting therapy efficacy from normalized biomarker scores
US20220319638A1 (en) Predicting response to treatments in patients with clear cell renal cell carcinoma
EP4423301B1 (en) Tumor microenvironment types in breast cancer
US20230290440A1 (en) Urothelial tumor microenvironment (tme) types
US20260038698A1 (en) Pan-cancer tumor microenvironment classification based on immune escape mechanisms and immune infiltration
US20220307088A1 (en) B cell-enriched tumor microenvironments
US20220290254A1 (en) B cell-enriched tumor microenvironments
WO2024151840A1 (en) Tumor microenvironment types in lung adenocarcinoma
HK40017854B (en) Systems and methods for identifying cancer treatments from normalized biomarker scores
HK40017854A (en) Systems and methods for identifying cancer treatments from normalized biomarker scores

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250729

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250729